Advertisement
Home »

Ixekizumab Resolves Nail Psoriasis Better Than Adalimumab in Psoriatic Arthritis

Jan 07, 2024

REFERENCES & ADDITIONAL READING

Smolen JS, et al. Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52. Ann Rheum Dis. 2020;79(10):1310-1319. doi:10.1136/annrheumdis-2020-217372.

 

McGonagle D, et al. Ixekizumab significantly improves nail disease and adjacent joint tenderness and swelling in psoriatic arthritis. P2231, ACR Convergence 2023, November 10–15, 2023, San Diego, USA.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement